US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.400
  • +0.110+3.34%
Close Apr 26 16:00 ET
  • 3.400
  • 0.0000.00%
Post 16:20 ET
354.33MMarket Cap-887P/E (TTM)

Revance Therapeutics Key Stats

Revance Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 28, 2024

Revenue(YoY)

69.80M

+39.82%
EPS(YoY)

-0.63

+65.38%

Buy

Mar 31, 2024

Revance Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 68.185M--
--2024/Q1-- / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--
Aug 8, 20232023/Q258.134M / 58.936M--
May 9, 20232023/Q149.331M / 46.211M--
Feb 28, 20232022/Q449.921M / 45.098M--
Nov 8, 20222022/Q329.015M / 28.238M--
Aug 9, 20222022/Q228.368M / 27.767M--
May 10, 20222022/Q125.261M / 23.874M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 68.185M--
--2024/Q1-- / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--
Aug 8, 20232023/Q258.134M / 58.936M--
May 9, 20232023/Q149.331M / 46.211M--
Feb 28, 20232022/Q449.921M / 45.098M--
Nov 8, 20222022/Q329.015M / 28.238M--
Aug 9, 20222022/Q228.368M / 27.767M--
May 10, 20222022/Q125.261M / 23.874M--

Unlock Free Earnings Estimates

Revance Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    70.00%
  • Hold

    30.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg